特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
621287

世界の創薬インフォマティクス市場:シーケンシング・データ分析、ドッキング、リードジェネレーション、標的同定・バリデーション 、分子モデリング) - 産業分析、市場規模、シェア、成長、動向、予測 2017年~2025年

Drug Discovery Informatics Market (Sequencing and Target Data Analysis, Docking, Lead Generation Informatics, Identification and Validation Informatics, Molecular Modeling) - Global Industry Analysis, Size, Share, Growth, Trends, Forecast 2017 - 2025

出版日: | 発行: Transparency Market Research | ページ情報: 英文 229 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
世界の創薬インフォマティクス市場:シーケンシング・データ分析、ドッキング、リードジェネレーション、標的同定・バリデーション 、分子モデリング) - 産業分析、市場規模、シェア、成長、動向、予測 2017年~2025年
出版日: 2018年03月08日
発行: Transparency Market Research
ページ情報: 英文 229 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の創薬インフォマティクス市場を調査し、市場の概要、製品・形態・機能・エンドユーザー・地域別の市場動向、市場規模の推移と予測、市場シェア、成長促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場セグメンテーション
  • 主な調査目的
  • 調査のハイライト

第2章 前提条件

第3章 調査手法

第4章 エグゼクティブサマリー

第5章 市場の概要

  • 概要
  • 主要産業のイベントと発展動向

第6章 市場のダイナミクス

  • 成長要因・阻害要因の分析
  • 成長要因
  • 阻害要因
  • 市場機会
  • 主要動向
  • ヘルスケア産業のIT支出:国別
  • 市場予測と分析
  • 市場の見通し

第7章 世界の創薬インフォマティクス市場の分析:製品別

  • イントロダクション
  • 主な発見/開発動向
  • 市場規模の推移と予測:製品別
    • 創薬インフォマティクス
    • 開発インフォマティクス
  • 比較分析:製品別
  • 市場魅力分析:製品別

第8章 世界の創薬インフォマティクス市場の分析:形態別

  • イントロダクション
  • 主な発見/開発動向
  • 市場規模の推移と予測:形態別
    • 自社
    • アウトソーシング
  • 比較分析:形態別
  • 市場魅力分析:形態別

第9章 世界の創薬インフォマティクス市場の分析:機能別

  • イントロダクション
  • 主な発見/開発動向
  • 市場規模の推移と予測:機能別
    • シーケンシング・データ解析
    • ドッキング
    • リードジェネレーション
    • 標的同定・バリデーション
    • 分子モデリング
    • その他
  • 比較分析:機能別
  • 市場魅力分析:機能別

第10章 世界の創薬インフォマティクス市場の分析:エンドユーザー別

  • イントロダクション
  • 主な発見/開発動向
  • 市場規模の推移と予測:エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • CRO(医薬品開発受託機関)
    • その他
  • 比較分析:エンドユーザー別
  • 市場魅力分析:エンドユーザー別

第11章 世界の創薬インフォマティクス市場の分析:地域別

  • 市場概要:地域別
  • 市場規模の推移と予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第12章 北米

第13章 欧州

第14章 アジア太平洋

第15章 ラテンアメリカ

第16章 中東・アフリカ

第17章 競合情勢

  • 企業プロファイル(詳細 - 概要、財務、最新動向、戦略)
    • Charles River Laboratories International, Inc.
    • Thermo Fisher Scientific
    • PerkinElmer Inc.
    • Biogen Inc.
    • Boehringer Ingelheim GmbH
    • Insilico Medicine, Inc.
    • International Business Machines Corporation
    • Schrodinger, LLC
    • Albany Molecular Research Inc. (AMRI)
    • Certara, LP
図表

List of Tables

  • Table 1: Opportunity Map, 2016
  • Table 2: Opportunity Map, 2016
  • Table 3: Opportunity Map, 2016
  • Table 4: Opportunity Map, 2016
  • Table 5: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Product, 2015-2025
  • Table 6: Global Drug Discovery Informatics Market mode (US$ Mn) Forecast, by Mode, 2015-2025
  • Table 7: Global Drug Discovery Informatics Market (US$ Mn) Forecast, by Function, 2015-2025
  • Table 8: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 9: Global Drug Discovery Informatics Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 10: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015-2025
  • Table 11: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015-2025
  • Table 12: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015-2025
  • Table 13: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 14: North America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Country, 2015-2025
  • Table 15: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015-2025
  • Table 16: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015-2025
  • Table 17: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015-2025
  • Table 18: Europe Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 19: Europe drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 20: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015-2025
  • Table 21: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015-2025
  • Table 22: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015-2025
  • Table 23: Asia Pacific Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 24: Asia Pacific drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 25: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015-2025
  • Table 26: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015-2025
  • Table 27: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015-2025
  • Table 28: Latin America Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 29: Latin America drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 30: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Product, 2015-2025
  • Table 31: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Mode, 2015-2025
  • Table 32: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by Function, 2015-2025
  • Table 33: Middle East & Africa Drug Discovery Informatics Market Value (US$ Mn) Forecast, by End-User, 2015-2025
  • Table 34: Middle East & Africa drug discovery informatics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015-2025

List of Figures

  • Figure 01: Global Drug Discovery Informatics Market, by Product, Market mode (US$ Mn), 2016 (A)
  • Figure 02: Global Drug Discovery Informatics Market Revenue (%), by Mode, 2016 (A)
  • Figure 03: Global Drug Discovery Informatics Market (US$ Mn) Forecast, 2015-2025
  • Figure 04: Global Drug Discovery Informatics Market Value Share, by product (2016)
  • Figure 05: Global Drug Discovery Informatics Market Value Share, by mode (2016)
  • Figure 06: Global Drug Discovery Informatics Market Value Share, by function (2016)
  • Figure 07: Global Drug Discovery Informatics Market Value Share, by end-user (2016)
  • Figure 08: Global Drug Discovery Informatics Market Value Share, by Product, 2016 and 2025
  • Figure 09: Global Drug Discovery Informatics Market Attractiveness, by Product, 2017-2025
  • Figure 10: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Discovery Informatics, 2015-2025
  • Figure 11: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Development Informatics, 2015-2025
  • Figure 12: Global Drug Discovery Informatics Market Value Share, by Mode, 2016 and 2025
  • Figure 13: Global Drug Discovery Informatics Market Attractiveness, by Mode, 2017-2025
  • Figure 14: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In-House Informatics, 2015-2025
  • Figure 15: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Outsourced Informatics, 2015-2025
  • Figure 16: Global Drug Discovery Informatics Market Value Share, by Function, 2016 and 2025
  • Figure 17: Global Drug Discovery Informatics Market Attractiveness, by Function, 2017-2025
  • Figure 18: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Sequencing and Target Data Analysis, 2015-2025
  • Figure 19: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Docking, 2015-2025
  • Figure 20: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lead Generation Informatics, 2015-2025
  • Figure 21: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Identification & Validation Informatics, 2015-2025
  • Figure 22: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Molecular Modelling, 2015-2025
  • Figure 23: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015-2025
  • Figure 24: Global Drug Discovery Informatics Market Value Share, by End-User, 2016 and 2025
  • Figure 25: Global Drug Discovery Informatics Market Attractiveness, by End-User, 2017-2025
  • Figure 26: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmaceutical & Biotechnology Companies, 2015-2025
  • Figure 27: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Contract Research Organizations, 2015-2025
  • Figure 28: Global Drug Discovery Informatics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015-2025
  • Figure 29: Global Drug Discovery Informatics Market Value Share, by Region, 2017 and 2025
  • Figure 30: Global Drug Discovery Informatics Market Attractiveness, by Region, 2017-2025
  • Figure 31: North America Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2025
  • Figure 32: North America Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 33: North America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
  • Figure 34: North America Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
  • Figure 35: North America Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 36: North America Drug Discovery Informatics Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 37: North America Drug Discovery Informatics Market Attractiveness Analysis, by Product
  • Figure 38: North America Drug Discovery Informatics Market Attractiveness Analysis, by Mode
  • Figure 39: North America Drug Discovery Informatics Market Attractiveness Analysis, by Function
  • Figure 40: North America Drug Discovery Informatics Market Attractiveness Analysis, by End-user
  • Figure 41: North America Drug Discovery Informatics Market Attractiveness Analysis, by Country
  • Figure 42: Europe Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2025
  • Figure 43: Europe Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 44: Europe Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
  • Figure 45: Europe Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
  • Figure 46: Europe Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 47: Europe drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 48: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Product
  • Figure 49: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Mode
  • Figure 50: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Function
  • Figure 51: Europe Drug Discovery Informatics Market Attractiveness Analysis, by End-user
  • Figure 52: Europe Drug Discovery Informatics Market Attractiveness Analysis, by Country
  • Figure 53: Asia Pacific Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2025
  • Figure 54: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 55: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
  • Figure 56: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
  • Figure 57: Asia Pacific Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 58: Asia Pacific drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 59: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Product
  • Figure 60: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Mode
  • Figure 61: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Function
  • Figure 62: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by End-user
  • Figure 63: Asia Pacific Drug Discovery Informatics Market Attractiveness Analysis, by Country/Sub Region
  • Figure 64: Latin America Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2025
  • Figure 65: Latin America Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 66: Latin America Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
  • Figure 67: Latin America Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
  • Figure 68: Latin America Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 69: Latin America drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 70: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Product
  • Figure 71: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Mode
  • Figure 72: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Function
  • Figure 73: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by End-user
  • Figure 74: Latin America Drug Discovery Informatics Market Attractiveness Analysis, by Country
  • Figure 75: Middle East & Africa Drug Discovery Informatics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2025
  • Figure 76: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Product, 2016 and 2025
  • Figure 77: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Mode, 2016 and 2025
  • Figure 78: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by Function, 2016 and 2025
  • Figure 79: Middle East & Africa Drug Discovery Informatics Market Value Share Analysis, by End-User, 2016 and 2025
  • Figure 80: Middle East & Africa drug discovery informatics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 81: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Product
  • Figure 82: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Mode
  • Figure 83: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Function
  • Figure 84: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by End-user
  • Figure 85: Middle East & Africa Drug Discovery Informatics Market Attractiveness Analysis, by Country
目次

Title:
Drug Discovery Informatics Market (Product - Discovery Informatics, Development Informatics; Mode - In-House Informatics, Outsourced Informatics; Function - Sequencing and Target Data Analysis, Docking, Lead Generation Informatics, Identification and Validation Informatics, Molecular Modeling; End Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Drug Discovery Informatics Market: Overview

This report on the Global Drug Discovery Informatics Market analyzes the current and future scenario of the global market. Rise in private and public funding for drug discovery informatics, and increasing number of uses of the drug discovery informatics such as the scientists use it to communicate their ideas with their colleagues in computational chemistry, and biology to design small parallel libraries, and to conduct their own preliminary analysis of interactions between the ligand and receptor are some of the factors expected to drive the growth of global Drug Discovery Informatics market during the forecast period.

The global Drug Discovery Informatics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on of product, mode, function, end-user, and geography. A detailed qualitative analysis of drivers and restraints, opportunities and trends have been provided in the market overview section. Additionally, the section comprises Healthcare IT expenditure to help understand the scope in the market. This section also provides market attractiveness analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global drug discovery informatics market.

Based on the product, the market is divided into development informatics, and discovery informatics. The discovery informatics segment dominated the market in terms of revenue in 2016, due to its cost benefits. Development informatics is anticipated to grow during the forecast period owing to the technological advancements in the development informatics. In terms of mode the market can be categorized into outsourced informatics, and in-house informatics. Outsourced informatics is estimated to dominate in terms of revenue in 2016 owing to the rise in collaborations and lead drug discovery projects between pharmaceutical companies, and IT market participants. In-house informatics is anticipated to grow in the coming years due to rise in the awareness regarding the time and cost benefits in the long run for the biotechnological and pharmaceutical companies.

Drug Discovery Informatics Market: Key Segments

Based on function the market can be classified into sequencing and target data analysis, docking, lead generation informatics, identification & validation informatics, molecular modeling, and others. Sequencing and target data analysis is estimated to dominate the market in 2016, owing to reduced cost of sequencing informatics. Molecular modeling segment is anticipated to grow during the forecast period owing to the increasing number of applications of small molecules in drug discovery. In terms of end-user the market can be divided into contract research organizations, pharmaceutical & biotechnology companies, and others. Contract research organizations (CROs) segment is estimated to dominate in 2016, owing to increasing number of CROs all over the world for drug discovery. Pharmaceutical and biotechnological companies segment is anticipated to grow during the forecast period owing to the long term time and cost benefits of the drug discovery informatics.

Geographically, the global drug discovery informatics market has been categorized into five major regions and the key countries in the respective region: North America (US and Canada), Europe (Germany, France, Italy, Spain, UK, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa).

The report also profiles major players in the global drug discovery informatics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Charles River Laboratories International, Inc., Thermo Fisher Scientific, PerkinElmer Inc., Biogen Inc., Boehringer Ingelheim GmbH, Insilico Medicine, Inc., International Business Machines Corporation, Schrodinger, LLC, Albany Molecular Research Inc. (AMRI), and Certara, L.P.

The global drug discovery informatics market has been segmented as below:

Global Drug Discovery Informatics Market, by Product

  • Discovery Informatics
  • Development Informatics

Global Drug Discovery Informatics Market, by Mode

  • In-House Informatics
  • Outsourced Informatics

Global Drug Discovery Informatics Market, by Function

  • Sequencing and Target Data Analysis
  • Docking
  • Lead Generation Informatics
  • Identification & Validation Informatics
  • Molecular Modeling
  • Others

Global Drug Discovery Informatics Market, by End-user

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others

Global Drug Discovery Informatics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Segmentation
  • 1.2. Key Research Objectives
  • 1.3. Research Highlights

2. Assumptions

3. Research Approach & Methodology

  • 3.1. Secondary Research Methodology
  • 3.2. Primary Research Methodology
  • 3.3. Analysis Research Methodology
  • 3.4. Final Report & Conclusions Research Methodology

4. Executive Summary: Global Drug Discovery Informatics Market

5. Market Overview

  • 5.1. Overview
  • 5.2. Key Industry Events and Developments

6. Market Dynamics

  • 6.1. Drivers and Restraints Snapshot Analysis
  • 6.2. Drivers
  • 6.3. Restraints
  • 6.4. Opportunity
  • 6.5. Key Trends
  • 6.6. Healthcare IT spending, by Countries
  • 6.6. Global Drug Discovery Informatics Market Forecast and Analysis
  • 6.7. Global Drug Discovery Informatics Market Outlook

7. Global Drug Discovery Informatics Market Analysis and Forecasts, By Product

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast by Product, 2015-2025
    • 7.3.1. Discovery Informatics
    • 7.3.2. Development Informatics
  • 7.4. Product Comparison Matrix
  • 7.5. Market Attractiveness by Product

8. Global Drug Discovery Informatics Market Analysis and Forecasts, By Mode

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast by Mode, 2015-2025
    • 8.3.1. In-House Informatics
    • 8.3.2. Outsourced Informatics
  • 8.4. Mode Comparison Matrix
  • 8.5. Market Attractiveness by Mode

9. Global Drug Discovery Informatics Market Analysis and Forecasts, By Function

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast by Function, 2015-2025
    • 9.3.1. Sequencing and Target Data Analysis
    • 9.3.2. Docking
    • 9.3.3. Lead Generation Informatics
    • 9.3.4. Identification & Validation Informatics
    • 9.3.5. Molecular Modeling
    • 9.3.6. Others
  • 9.4. Function Comparison Matrix
  • 9.5. Market Attractiveness by Function

10. Global Drug Discovery Informatics Market Analysis and Forecasts, By End-User

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast by End-User, 2015-2025
    • 10.3.1. Pharmaceutical & Biotechnology Companies
    • 10.3.2. Contract Research Organizations
    • 10.3.3. Others
  • 10.4. End-User Comparison Matrix
  • 10.5. Market Attractiveness by End-User

11. Global Drug Discovery Informatics Market Analysis and Forecasts, By Region

  • 11.1. Global Drug Discovery Informatics Market Snapshot, by Country
  • 11.2. Market Value Forecast by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness by Country/Region

12. North America Global Drug Discovery Informatics Market Analysis and Forecast

  • 12.1. Key Findings
  • 12.2. North America Global Drug Discovery Informatics Market Overview
  • 12.3. Market Value Share Analysis by Product, 2015-2025
    • 12.3.1. Discovery Informatics
    • 12.3.2. Development Informatics
  • 12.4. Market Value Share Analysis by Mode, 2015-2025
    • 12.4.1. In-House Informatics
    • 12.4.2. Outsourced Informatics
  • 12.5. Market Value Share Analysis by Function, 2015-2025
    • 12.5.1. Sequencing and Target Data Analysis
    • 12.5.2. Docking
    • 12.5.3. Lead Generation Informatics
    • 12.5.4. Identification & Validation Informatics
    • 12.5.5. Molecular Modeling
    • 12.5.6. Others
  • 12.6. Market Value Share Analysis by End-User, 2015-2025
    • 12.6.1. Pharmaceutical & Biotechnology Companies
    • 12.6.2. Contract Research Organizations
    • 12.6.3. Others
  • 12.7. Market Value Share Analysis by Country, 2015-2025
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Product
    • 12.8.2. By Mode
    • 12.8.3. By Function
    • 12.8.4. By End-User
    • 12.8.5. By Country
  • 12.9. Market Trends

13. Europe Global Drug Discovery Informatics Market Analysis and Forecast

  • 13.1. Key Findings
  • 13.2. Europe Global Drug Discovery Informatics Market Overview
  • 13.3. Market Value Share Analysis by Product, 2015-2025
    • 13.3.1. Discovery Informatics
    • 13.3.2. Development Informatics
  • 13.4. Market Value Share Analysis by Mode, 2015-2025
    • 13.4.1. In-House Informatics
    • 13.4.2. Outsourced Informatics
  • 13.5. Market Value Share Analysis by Function, 2015-2025
    • 13.5.1. Sequencing and Target Data Analysis
    • 13.5.2. Docking
    • 13.5.3. Lead Generation Informatics
    • 13.5.4. Identification & Validation Informatics
    • 13.5.5. Molecular Modeling
    • 13.5.6. Others
  • 13.6. Market Value Share Analysis by End-User, 2015-2025
    • 13.6.1. Pharmaceutical & Biotechnology Companies
    • 13.6.2. Contract Research Organizations
    • 13.6.3. Others
  • 13.7. Market Value Share Analysis by Country, 2015-2025
    • 13.7.1. Germany
    • 13.7.2. France
    • 13.7.3. Italy
    • 13.7.4. Spain
    • 13.7.5. UK
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Product
    • 13.8.2. By Mode
    • 13.8.3. By Function
    • 13.8.4. By End-User
    • 13.8.5. By Country
  • 13.9. Market Trends

14. Asia Pacific Global Drug Discovery Informatics Market Analysis and Forecast

  • 14.1. Key Findings
  • 14.2. Asia Pacific Global Drug Discovery Informatics Market Overview
  • 14.3. Market Value Share Analysis by Product, 2015-2025
    • 14.3.1. Discovery Informatics
    • 14.3.2. Development Informatics
  • 14.4. Market Value Share Analysis by Mode, 2015-2025
    • 14.4.1. In-House Informatics
    • 14.4.2. Outsourced Informatics
  • 14.5. Market Value Share Analysis by Function, 2015-2025
    • 14.5.1. Sequencing and Target Data Analysis
    • 14.5.2. Docking
    • 14.5.3. Lead Generation Informatics
    • 14.5.4. Identification & Validation Informatics
    • 14.5.5. Molecular Modeling
    • 14.5.6. Others
  • 14.6. Market Value Share Analysis by End-User, 2015-2025
    • 14.6.1. Pharmaceutical & Biotechnology Companies
    • 14.6.2. Contract Research Organizations
    • 14.6.3. Others
  • 14.7. Market Value Share Analysis by Country, 2015-2025
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Product
    • 14.8.2. By Mode
    • 14.8.3. By Function
    • 14.8.4. By End-User
    • 14.8.5. By Country
  • 14.9. Market Trends

15. Latin America Global Drug Discovery Informatics Market Analysis and Forecast

  • 15.1. Key Findings
  • 15.2. Latin America Global Drug Discovery Informatics Market Overview
  • 15.3. Market Value Share Analysis by Product, 2015-2025
    • 15.3.1. Discovery Informatics
    • 15.3.2. Development Informatics
  • 15.4. Market Value Share Analysis by Mode, 2015-2025
    • 15.4.1. In-House Informatics
    • 15.4.2. Outsourced Informatics
  • 15.5. Market Value Share Analysis by Function, 2015-2025
    • 15.5.1. Sequencing and Target Data Analysis
    • 15.5.2. Docking
    • 15.5.3. Lead Generation Informatics
    • 15.5.4. Identification & Validation Informatics
    • 15.5.5. Molecular Modeling
    • 15.5.6. Others
  • 15.6. Market Value Share Analysis by End-User, 2015-2025
    • 15.6.1. Pharmaceutical & Biotechnology Companies
    • 15.6.2. Contract Research Organizations
    • 15.6.3. Others
  • 15.7. Market Value Share Analysis by Country, 2015-2025
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Product
    • 15.8.2. By Mode
    • 15.8.3. By Function
    • 15.8.4. By End-User
    • 15.8.5. By Country
  • 15.9. Market Trends

16. Middle East & Africa Global Drug Discovery Informatics Market Analysis and Forecast

  • 16.1. Key Findings
  • 16.2. Middle East & Africa Global Drug Discovery Informatics Market Overview
  • 16.3. Market Value Share Analysis by Product, 2016-2025
    • 16.3.1. Discovery Informatics
    • 16.3.2. Development Informatics
  • 16.4. Market Value Share Analysis by Mode, 2016-2025
    • 16.4.1. In-House Informatics
    • 16.4.2. Outsourced Informatics
  • 16.5. Market Value Share Analysis by Function, 2016-2025
    • 16.5.1. Sequencing and Target Data Analysis
    • 16.5.2. Docking
    • 16.5.3. Lead Generation Informatics
    • 16.5.4. Identification & Validation Informatics
    • 16.5.5. Molecular Modeling
    • 16.5.6. Others
  • 16.6. Market Value Share Analysis by End-User, 2016-2025
    • 16.6.1. Pharmaceutical & Biotechnology Companies
    • 16.6.2. Contract Research Organizations
    • 16.6.3. Others
  • 16.7. Market Value Share Analysis by Country, 2016-2025
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Product
    • 16.8.2. By Mode
    • 16.8.3. By Function
    • 16.8.4. By End-User
    • 16.8.5. By Country
  • 16.9. Market Trends

17. Competition Landscape

  • 17.1. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 17.1.1. Charles River Laboratories International, Inc.
      • 17.1.1.1. Company Description
      • 17.1.1.2. Financial Overview
      • 17.1.1.3. Strategic Overview
      • 17.1.1.4. Recent Developments
      • 17.1.1.5. SWOT ANALYSIS
    • 17.1.2. Thermo Fisher Scientific
      • 17.1.2.1. Company Description
      • 17.1.2.2. Financial Overview
      • 17.1.2.3. Strategic Overview
      • 17.1.2.4. Recent Developments
      • 17.1.2.5. SWOT ANALYSIS
    • 17.1.3. PerkinElmer Inc.
      • 17.1.3.1. Company Description
      • 17.1.3.2. Financial Overview
      • 17.1.3.3. Strategic Overview
      • 17.1.3.4. Recent Developments
      • 17.1.3.5. SWOT ANALYSIS
    • 17.1.4. Biogen Inc.
      • 17.1.4.1. Company Description
      • 17.1.4.2. Financial Overview
      • 17.1.4.3. Strategic Overview
      • 17.1.4.4. Recent Developments
      • 17.1.4.5. SWOT ANALYSIS
    • 17.1.5. Boehringer Ingelheim GmbH
      • 17.1.5.1. Company Description
      • 17.1.5.2. Financial Overview
      • 17.1.5.3. Strategic Overview
      • 17.1.5.4. Recent Developments
      • 17.1.5.5. SWOT ANALYSIS
    • 17.1.6. Insilico Medicine, Inc.
      • 17.1.6.1. Company Description
      • 17.1.6.2. Strategic Overview
      • 17.1.6.3. SWOT ANALYSIS
    • 17.1.7. International Business Machines Corporation
      • 17.1.7.1. Company Description
      • 17.1.7.2. Financial Overview
      • 17.1.7.3. Strategic Overview
      • 17.1.7.4. SWOT ANALYSIS
    • 17.1.8. Schrodinger, LLC
      • 17.1.8.1. Company Description
      • 17.1.8.2. Strategic Overview
      • 17.1.8.3. SWOT ANALYSIS
    • 17.1.9. Albany Molecular Research Inc. (AMRI)
      • 17.1.9.1. Company Description
      • 17.1.9.2. Strategic Overview
      • 17.1.9.3. SWOT ANALYSIS
    • 17.1.10. Certara, L.P
      • 17.1.10.1. Company Description
      • 17.1.10.2. Strategic Overview
      • 17.1.10.3. SWOT ANALYSIS
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.